Apheresis in patients with severe sepsis and multi organ dysfunction syndrome (Q37168771)

18 August 2017

1 reference

title

Apheresis in patients with severe sepsis and multi organ dysfunction syndrome (English)

1 reference

18 August 2017

0 references

Bernd Stegmayr

1

1 reference

18 August 2017

19 May 2008

1 reference

Transfusion and Apheresis Science

18 August 2017

1 reference

18 August 2017

38

1 reference

18 August 2017

3

1 reference

18 August 2017

203-208

1 reference

The pathogenesis of septic acute renal failure

18 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

RIFLE classification is predictive of short-term prognosis in critically ill patients with acute renal failure supported by extracorporeal membrane oxygenation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Efficacy and safety of recombinant human activated protein C for severe sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

The epidemiology of sepsis in the United States from 1979 through 2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Plasma exchange as rescue therapy in multiple organ failure including acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Pathogenesis of group A streptococcal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Cytotoxic effects of streptolysin o and streptolysin s enhance the virulence of poorly encapsulated group a streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Streptococcal M5 protein prevents neutrophil phagocytosis by interfering with CD11b/CD18 receptor-mediated association and signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Cleavage of antigen-bound immunoglobulin G by SpeB contributes to streptococcal persistence in opsonizing blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Biology and pathogenesis of thrombosis and procoagulant activity in invasive infections caused by group A streptococci and Clostridium perfringens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Host genetic determinants of Neisseria meningitidis infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Tumor necrosis factor ? in the pathogenesis of cerebral malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Clinical trials of mediator-directed therapy in sepsis: what have we learned?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

C1-inhibitor in patients with severe sepsis and septic shock: beneficial effect on renal dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Continuous renal replacement therapies: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Blood purification in the intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

A survey of blood purification techniques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Complement activation in plasma exchange by single filtration and centrifugation and in cascade filtration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Adsorption of microorganism components by lixelle beads

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Extracorporeal removal of proinflammatory cytokines by specific absorption onto microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Is there a future for adsorption techniques in sepsis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Preparation of a superantigen-adsorbing device and its superantigen removal efficacies in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Sorbents in Acute Renal Failure and End-Stage Renal Disease: Middle Molecule and Cytokine Removal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

A new endotoxin adsorption device in Gram-negative sepsis: use of immobilized albumin with the MATISSE adsorber.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

HELP apheresis in the treatment of sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Plasmapheresis combined with continuous venovenous hemofiltration in surgical patients with sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Outcome of patients with sepsis and septic shock after ICU treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Epidemiology and prognostic factors of critically ill patients treated with hemodiafiltration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Prognosis in Septicemia Complicated by Acute Renal Failure Requiring Dialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Prognostic stratification in critically ill patients with acute renal failure requiring dialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Renal involvement in the systemic inflammatory reaction syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Low-flux versus high-flux synthetic dialysis membrane in acute renal failure: prospective randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin B immobilized column

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Septic shock induced by group A streptococcal infection: clinical and therapeutic aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Plasma and whole blood exchange in meningococcal sepsis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Plasmapheresis in the treatment of primary septic shock in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

Plasma exchange in patients with acute renal failure in the course of multiorgan failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

The presence of superantigens and complex host responses in severe sepsis may need a broad therapeutic approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Apheresis as therapy for patients with severe sepsis and multiorgan dysfunction syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.03.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRANSCI.2008.03.009

1 reference

18 August 2017

1 reference

PubMed ID

18492616